BindingDB logo
myBDB logout

187 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28246041 13 Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents.EBI Svkm'S Dr. Bhanuben Nanavati College of Pharmacy
28189906 25 Dregamine and tabernaemontanine derivatives as ABCB1 modulators on resistant cancer cells.EBI Universidade De Lisboa
27676469 64 Phenyltetrazolyl-phenylamides: Substituent impact on modulation capability and selectivity toward the efflux protein ABCG2 and investigation of interaction with the transporter.EBI Rheinische Friedrich-Wilhelms-Universit£T Bonn
27504669 39 Hernandezine, a Bisbenzylisoquinoline Alkaloid with Selective Inhibitory Activity against Multidrug-Resistance-Linked ATP-Binding Cassette Drug Transporter ABCB1.EBI Chang Gung Memorial Hospital
27727127 16 Halogenated naphthochalcones and structurally related naphthopyrazolines with antitumor activity.EBI University Bayreuth
27131064 22 Synthesis and bioevaluation of novel benzodipyranone derivatives as P-glycoprotein inhibitors for multidrug resistance reversal agents.EBI China Medical University
27262425 14 Structure-activity relationships of dibenzoylhydrazines for the inhibition of P-glycoprotein-mediated quinidine transport.EBI Kyoto University
27100033 40 The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2).EBI University of Bonn
26836364 30 Optimization by Molecular Fine Tuning of Dihydro-ß-agarofuran Sesquiterpenoids as Reversers of P-Glycoprotein-Mediated Multidrug Resistance.EBI Instituto Universitario De Bio-Org£Nica&Quot;Antonio Gonz£Lez&Quot
26774038 67 Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization.EBI University of Regensburg
26123642 38 The interaction of 4-thiazolidinone derivatives containing indolin-2-one moiety with P-glycoprotein studied using K562 cell lines.EBI The First Affiliated Hospital of Dalian Medical University
26233798 11 Optimization of permethyl ningalin B analogs as P-glycoprotein inhibitors.EBI Ocean University of China
26048803 3 Discovery of substituted 1,4-dihydroquinolines as novel promising class of P-glycoprotein inhibitors: First structure-activity relationships and bioanalytical studies.EBI Martin-Luther-University Halle-Wittenberg
25985195 94 Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.EBI The Hong Kong Polytechnic University
25695368 4 Restoration of Chemosensitivity in P-Glycoprotein-Dependent Multidrug-Resistant Cells by Dihydro-ß-agarofuran Sesquiterpenes from Celastrus vulcanicola.EBI Instituto Universitario De Bio-Org£Nica Antonio Gonz£Lez (Iubo-Ag)
23132334 28 In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.EBI Glaxosmithkline
25855895 23 HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2).EBI University of Bonn
25093931 44 Trimethoxybenzanilide-based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding.EBI Universit£
25499431 4 Investigating the binding interactions of the anti-Alzheimer's drug donepezil with CYP3A4 and P-glycoprotein.EBI University of Waterloo
25462276 39 Deconstruction of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety to separate P-glycoprotein (P-gp) activity froms2 receptor affinity in mixed P-gp/s2 receptor agents.EBI Universit£
25379609 24 SAR studies on tetrahydroisoquinoline derivatives: the role of flexibility and bioisosterism to raise potency and selectivity toward P-glycoprotein.EBI Universit£
25310383 50 Potent nonimmunosuppressive cyclophilin inhibitors with improved pharmaceutical properties and decreased transporter inhibition.EBI Novartis Institutes For Biomedical Research
24952376 2 4,5-Di-substituted benzyl-imidazol-2-substituted amines as the structure template for the design and synthesis of reversal agents against P-gp-mediated multidrug resistance breast cancer cells.EBI Ocean University of China
24773054 11 Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole amino acid.EBI St. John'S University
24613626 21 Synthesis, biological evaluation and 3D-QSAR studies of new chalcone derivatives as inhibitors of human P-glycoprotein.EBI Medical University Vienna
24607999 16 SAR study on arylmethyloxyphenyl scaffold: looking for a P-gp nanomolar affinity.EBI Universit£
24184213 71 Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2).EBI University of Bonn
24161678 9 Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging ofs2 receptors.EBI Universit£
23332369 5 Synthesis of N(4)-(substituted phenyl)-N(4)-alkyl/desalkyl-9H-pyrimido[4,5-b]indole-2,4-diamines and identification of new microtubule disrupting compounds that are effective against multidrug resistant cells.EBI Duquesne University
23374872 27 Potent and selective tariquidar bioisosters as potential PET radiotracers for imaging P-gp.EBI Universit£
23347803 29 Naphthalenyl derivatives for hitting P-gp/MRP1/BCRP transporters.EBI Universit£
24900683 26 Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators.EBI University of Regensburg
21723648 41 Docking and 3D-QSAR (quantitative structure activity relationship) studies of flavones, the potent inhibitors of p-glycoprotein targeting the nucleotide binding domain.EBI Chosun University
15331656 2 Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A).EBI Institute of Cancer Research
15359574 1 Transport characteristics of fexofenadine in the Caco-2 cell model.EBI Uppsala University
9914792 3 Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein.EBI Kobe University
11145223 7 Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4.EBI Kanazawa University
11231118 8 Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport.EBI Kanazawa University
7562598 1 Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein.EBI Kyoto University Hospital
8862725 8 Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay.EBI Strasbourg 1 University
12134945 9 Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?EBI The University of Kansas
11474784 6 HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein.EBI Schering-Plough Research Institute
11743742 6 Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4.EBI Schering-Plough Research Institute
11606389 1 The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein.EBI Schering-Plough Research Institute
11027568 1 Cholesterol interaction with the daunorubicin binding site of P-glycoprotein.EBI Schering-Plough Research Institute
11452702 1 P-glycoprotein interactions of nefazodone and trazodone in cell culture.EBI Tufts University School of Medicine
11408360 1 Methadone inhibits rhodamine123 transport in Caco-2 cells.EBI Tufts University School of Medicine
11454724 3 Evaluation of the interaction of loratadine and desloratadine with P-glycoprotein.EBI Schering-Plough Research Institute
11716514 103 Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.EBI Schering-Plough Research Institute
11751127 2 Interaction of common azole antifungals with P glycoprotein.EBI Schering-Plough Research Institute
10820137 13 Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes.EBI Vanderbilt University School of Medicine
12700464 1 Lopinavir: acute exposure inhibits P-glycoprotein; extended exposure induces P-glycoprotein.EBI Tufts University School of Medicine
10901697 1 Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.EBI Vanderbilt University School of Medicine
11964599 4 Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein.EBI Vanderbilt University
11770010 3 Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.EBI Institute of Clinical Pharmacology
10773005 2 Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.EBI Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
10729360 1 Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.EBI Universit£
15240100 12 Reversal of P-glycoprotein-mediated MDR by 5,7,3',4',5'-pentamethoxyflavone and SAR.EBI Chosun University
15616150 14 Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1.EBI Pfizer
12569305 12 Differential effects of the optical isomers of KR30031 on cardiotoxicity and on multidrug resistance reversal activity.EBI Korea Research Institute of Chemical Technology
14755051 1 Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine.EBI Washington University
10411602 2 Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities.EBI Eli Lilly
17890094 35 New functional assay of P-glycoprotein activity using Hoechst 33342.EBI University of Bonn
16722621 3 New potent P-glycoprotein inhibitors carrying a polycyclic scaffold.EBI University of Bologna
15481991 2 Increased anti-P-glycoprotein activity of baicalein by alkylation on the A ring.EBI Yale University
11784143 4 C-7 analogues of progesterone as potent inhibitors of the P-glycoprotein efflux pump.EBI Georgetown University School of Medicine
10386932 56 Synthesis and evaluation of hapalosin and analogs as MDR-reversing agents.EBI Eisai Research Institute
22727780 17 Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).EBI The State University of New York
22541068 73 Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.EBI Uppsala University
12604693 1 Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: role of CYP3A and P-glycoprotein.EBI Merck Research Laboratories
11961113 36 Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.EBI Eli Lilly
9751076 2 Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.EBI Eli Lilly
12130727 2 Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.EBI Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
10198227 3 PSC833, cyclosporin A, and dexniguldipine effects on cellular calcein retention and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.EBI University of Tennessee Medical Center
19721074 1 Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system.EBI F. Hoffmann-La Roche
24900226 3 From taxuspine x to structurally simplified taxanes with remarkable p-glycoprotein inhibitory activity.EBI TBA
17664327 10 Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro.EBI Gilead Sciences
19170519 34 Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.EBI University of Regensburg
18083034 70 Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors.EBI University of Bonn
17936633 16 Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.EBI Universit£
18257545 34 Synthesis and biological evaluation of (hetero)arylmethyloxy- and arylmethylamine-phenyl derivatives as potent P-glycoprotein modulating agents.EBI Universita Degli Studi Di Bari
17352460 159 Self-organizing maps for identification of new inhibitors of P-glycoprotein.EBI University of Vienna
16686543 44 Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells.EBI Universit£
12699389 152 Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.EBI F. Hoffmann-La Roche
12477351 41 Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).EBI Bulgarian Academy of Sciences
12361387 59 Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.EBI Strasbourg 1 University
10891114 28 Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter.EBI Strasbourg 1 University
9767638 24 Substituted 4-acylpyrazoles and 4-acylpyrazolones: synthesis and multidrug resistance-modulating activity.EBI University of Vienna
22112208 98 Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein.EBI Universit£
21856049 8 Overcoming human P-glycoprotein-dependent multidrug resistance with novel dihydro-ß-agarofuran sesquiterpenes.EBI Instituto Universitario De Bio-Org£Nica Antonio Gonz£Lez (Iubo-Ag)
21570282 28 Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2).EBI Universidad Nacional De Colombia
21341745 4 A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields.EBI University of Perugia
21189339 5 Interaction potential of etravirine with drug transporters assessed in vitro.EBI University Hospital Heidelberg
21354800 77 Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).EBI University of Bonn
20731360 6 Potent and fully noncompetitive peptidomimetic inhibitor of multidrug resistance P-glycoprotein.EBI Umr 5086 Cnrs
20684594 71 Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein.EBI Universita Degli Studi Di Torino
19819706 16 Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone.EBI Philipps-Universit£T Marburg
19402665 29 Rhodamine inhibitors of P-glycoprotein: an amide/thioamide"switch" for ATPase activity.EBI The State University of New York
19053888 114 2-[(3-Methoxyphenylethyl)phenoxy]-based ABCB1 inhibitors: effect of different basic side-chains on their biological properties.EBI Universita Degli Studi Di Bari
18954040 5 Bis-pyranobenzoquinones as a new family of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in mammalian cells and the protozoan parasite Leishmania.EBI Instituto Universitario De Bio-OrgáNica Antonio GonzáLez
18524592 4 Effect of some P-glycoprotein modulators on Rhodamine-123 absorption in guinea-pig ileum.EBI Università
17850057 72 Biological evaluation, structure-activity relationships, and three-dimensional quantitative structure-activity relationship studies of dihydro-beta-agarofuran sesquiterpenes as modulators of P-glycoprotein-dependent multidrug resistance.EBI Instituto Universitario De Bio-Organica Antonio Gonzalez
17399990 45 In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2).EBI Université
17064079 22 Arylmethyloxyphenyl derivatives: small molecules displaying P-glycoprotein inhibition.EBI Università
16640345 9 Biological evaluation of bishydroxymethyl-substituted cage dimeric 1,4-dihydropyridines as a novel class of p-glycoprotein modulating agents in cancer cells.EBI Martin-Luther-University Halle-Wittenberg
16458504 37 Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: a novel agonist 5-HT1A receptor PET ligand.EBI Columbia University College of Physicians and Surgeons
16392798 46 Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.EBI Columbia University College of Physicians and Surgeons
11958985 21 Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1).EBI Eli Lilly
32347726 41 Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs.EBI Taipei Chang Gung Memorial Hospital
32329342 23 Discovery of Potent Inhibitors against P-Glycoprotein-Mediated Multidrug Resistance Aided by Late-Stage Functionalization of a 2-(4-(Pyridin-2-yl)phenoxy)pyridine Analogue.EBI Chinese Academy of Medical Sciences & Peking Union Medical College
31975579 9 Chrysosporazines F-M: P-Glycoprotein Inhibitory Phenylpropanoid Piperazines from an Australian Marine Fish Derived Fungus, EBI The University of Queensland
27280693 83 Synthesis and Investigation of Tetrahydro-?-carboline Derivatives as Inhibitors of the Breast Cancer Resistance Protein (ABCG2).EBI University of Bonn
27336199 36 Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4'-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein.EBI Universit£
27148793 112 Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2).EBI University of Bonn
30860373 18 Jatrophane Diterpenoids from Euphorbia glomerulans.EBI Chinese Academy of Sciences
30594677 62 Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2.EBI Rheinische Friedrich-Wilhelms-University of Bonn
30584838 44 Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells.EBI Universit£
31505928 17 Potential Tools for Eradicating HIV Reservoirs in the Brain: Development of Trojan Horse Prodrugs for the Inhibition of P-Glycoprotein with Anti-HIV-1 Activity.EBI Purdue University
30947123 26 Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.EBI University of Florence
31200236 6 Tetrazole hybrids with potential anticancer activity.EBI Henan University of Chinese Medicine
31505451 9 Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance.EBI Yantai University
31494468 61 Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers.EBI University of Florence
31325783 34 Design, synthesis and biological evaluation of chalcones as reversers of P-glycoprotein-mediated multidrug resistance.EBI East China University of Science and Technology
31702922 55 Optimizing Targeted Inhibitors of P-Glycoprotein Using Computational and Structure-Guided Approaches.EBI TBA
31103904 7 Natural products as multidrug resistance modulators in cancer.EBI Central University of Punjab
30925062 34 Identification of Thienopyrimidine Scaffold as an Inhibitor of the ABC Transport Protein ABCC1 (MRP1) and Related Transporters Using a Combined Virtual Screening Approach.EBI Rheinische Friedrich-Wilhelms-University of Bonn
30390439 51 Synthesis and biological evaluation of quinazoline derivatives - A SAR study of novel inhibitors of ABCG2.EBI University of Bonn
30384046 47 1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1.EBI Universit£
30384042 13 Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents.EBI Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University)
30347326 5 Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.EBI Universities of Shandong
31465686 355 Triazole Bridged Flavonoid Dimers as Potent, Nontoxic, and Highly Selective Breast Cancer Resistance Protein (BCRP/ABCG2) Inhibitors.EBI Hong Kong Polytechnic University
31585275 8 Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.EBI Jinan University
25282263 20 Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters.EBI Universit£
25250825 1 Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cells.EBI The State University of New York
24273637 17 Homodimers of the Antiviral Abacavir as Modulators of P-glycoprotein Transport in Cell Culture: Probing Tether Length.EBI Purdue University
24171478 4 Structure-activity relationship study of permethyl ningalin B analogues as P-glycoprotein chemosensitizers.EBI Ocean University of China
23895532 11 Structure-activity relationship and in vitro and in vivo evaluation of the potent cytotoxic anti-microtubule agent N-(4-methoxyphenyl)-N,2,6-trimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-aminium chloride and its analogues as antitumor agents.EBI Duquesne University
23683834 3 20(S)-Protopanaxadiol (PPD) analogues chemosensitize multidrug-resistant cancer cells to clinical anticancer drugs.EBI Chinese Academy of Sciences
23245571 30 New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR).EBI Universit£
22320402 4 Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation.EBI The Hong Kong Polytechnic University
22533905 2 Chalcogenopyrylium compounds as modulators of the ATP-binding cassette transporters P-glycoprotein (P-gp/ABCB1) and multidrug resistance protein 1 (MRP1/ABCC1).EBI The State University of New York
12235267 37 Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.EBI St. Jude Children'S Research Hospital
12128170 10 Effects of 12 Ca2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression.EBI Kyoto Pharmaceutical University
12636153 6 Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.EBI The University of Kansas
12649369 6 Inhibition of P-glycoprotein by newer antidepressants.EBI University of Heidelberg
11405287 7 A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells.EBI The University of Kansas
8960059 1 Reversal of P-glycoprotein-associated multidrug resistance by ivermectin.EBI Institute of Parasitology of Mcgill University
10997946 2 Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.EBI University of Tokyo
11914912 1 P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel.EBI Nihon Schering K.K.
12235265 1 Sirolimus oral absorption in rats is increased by ketoconazole but is not affected by D-alpha-tocopheryl poly(ethylene glycol 1000) succinate.EBI Avmax
7514263 1 Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein.EBI University of North Carolina
9313931 1 Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein.EBI Novartis Takarazuka Research Institute
15386482 1 Interactions of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen with P-glycoprotein and CYP3A.EBI Tufts University School of Medicine
22452412 31 Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.EBI University of Vienna
22632934 8 Click chemistry-derived bivalent quinine inhibitors of P-glycoprotein-mediated cellular efflux.EBI Purdue University
19783433 22 Analogs of a 4-aminothieno[2,3-d]pyrimidine lead (QB13) as modulators of P-glycoprotein substrate specificity.EBI University of Bonn
19250834 43 Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators.EBI University of Bonn
30308411 1 Discovery of traditional Chinese medicine monomers and their synthetic intermediates, analogs or derivatives for battling P-gp-mediated multi-drug resistance.EBI Anhui University of Chinese Medicine
29287249 13 Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (?EBI Universit£
29407974 39 Structure activity relationships, multidrug resistance reversal and selectivity of heteroarylphenyl ABCG2 inhibitors.EBI Rheinische Friedrich-Wilhelms-Universit£T Bonn
28675836 6 Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.EBI Csir - Indian Institute of Integrative Medicine
30150104 18 Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR).EBI Zhengzhou University
28841513 117 Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2).EBI University of Bonn
28645831 41 Synthesis and biological evaluation of JL-A7 derivatives as potent ABCB1 inhibitors.EBI China Pharmaceutical University
28301155 2 Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance.EBI China Pharmaceutical University
28712845 5 Dual inhibitors of the human blood-brain barrier drug efflux transporters P-glycoprotein and ABCG2 based on the antiviral azidothymidine.EBI Purdue University
29251928 4 Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-Glycoprotein.EBI St. John'S University
28434782 11 Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter.EBI University of Montana
28471656 91 4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2).EBI University of Bonn
 35 Cycloalkylpiperazines as HIV-1 Protease Inhibitors: Enhanced Oral AbsorptionBDB Merck Research Laboratories